Valuation: BrainsWay Ltd.

Market Cap 619M 0 536M 499M 459M 867M 58.82B 877M 5.87B 2.3B 29.43B 2.32B 2.27B 97.48B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 619M 0 536M 499M 459M 867M 58.82B 877M 5.87B 2.3B 29.43B 2.32B 2.27B 97.48B EV / Sales 2026 *
9.14x
EV / Sales 2027 * 7.49x
Free-Float
90.49%
Yield 2026 *
-
Yield 2027 * -
1 week-1.76%
Current month-5.37%
1 month-2.63%
3 months-3.62%
6 months+39.23%
Current year+48.32%
1 week 4,582
Extreme 4582
4,898
1 month 4,212
Extreme 4212
5,165
Current year 3,080
Extreme 3080
5,165
1 year 2,021
Extreme 2021
5,165
3 years 435
Extreme 435
5,165
5 years 272
Extreme 272
5,165
10 years 272
Extreme 272
5,165
Manager TitleAgeSince
Chief Executive Officer 54 13/02/2023
Chief Tech/Sci/R&D Officer 56 01/05/2006
Director of Finance/CFO 50 23/05/2023
Director TitleAgeSince
Chairman 74 01/01/2003
Director/Board Member 70 01/11/2006
Director/Board Member 56 17/06/2019
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Director

37,500 0.0956%
18/03/26 Other

Chief Technology Officer

63,881 0.1629%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.76%+125.00%+930.92% 619M
+2.32%+0.24%+23.89%+5.32% 214B
+2.51%+1.61%+0.31%-21.63% 140B
+1.88%+6.26%-21.34%+21.30% 133B
-2.75%+3.69%-54.46%-5.88% 69.19B
-0.70%+3.74%+12.28%+11.84% 51.28B
+0.38%+6.05%-13.51%-19.14% 50.43B
+1.37%+0.58%+22.82%+11.73% 39.85B
+0.99%+5.41%+42.25%+37.98% 39.27B
+0.40%+4.55%-21.39%+24.98% 32.32B
Average +0.43%+3.80%+11.59%+99.74% 76.95B
Weighted average by Cap. +0.93%+3.04%+0.59%+4.55%

Financials

2026 *2027 *
Net sales 67.65M 0 58.59M 54.62M 50.23M 94.83M 6.43B 95.89M 642M 252M 3.22B 254M 248M 10.66B 82.64M 0 71.58M 66.72M 61.37M 116M 7.86B 117M 784M 308M 3.93B 310M 304M 13.02B
Net income 12.42M 0 10.76M 10.03M 9.22M 17.41M 1.18B 17.61M 118M 46.25M 591M 46.65M 45.62M 1.96B 19.74M 0 17.09M 15.93M 14.65M 27.67M 1.88B 27.98M 187M 73.49M 939M 74.12M 72.49M 3.11B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
129
Date Price Change Volume
06/08/26 ILA 4,635.00 0.00% 2,332
05/08/26 ILA 4,635.00 -3.24% 46,519
04/08/26 ILA 4,790.00 +0.27% 42,052
03/08/26 ILA 4,777.00 -2.47% 84,444
31/07/26 ILA 4,898.00 +3.82% 72,131

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BWAY Stock